使用数据挖掘算法和网络药理学探索阿帕胺的皮肤不良事件和机制
Yaqing Chen1, Longzhuan Huang1, Wenwei Li1
1Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
Frontiers in pharmacology
|February 28, 2025
概括
阿帕胺的使用与严重的皮肤反应有关,例如有毒的表皮解. 这项研究表明,阿帕胺可能与JAK1和JAK2结合,可能导致这些不良事件,需要仔细监测.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 毒理学 毒理学 毒理学
背景情况:
- 阿帕胺与显著的皮肤不良事件有关,包括有毒的表皮解,使其临床应用复杂化.
- 识别这些反应背后的机制对于患者的安全和治疗疗效至关重要.
研究的目的:
- 研究将阿帕胺与皮肤不良事件联系在一起的途径,特别是斯蒂芬·约翰逊综合征/有毒表皮解.
- 为临床监测和进一步研究阿帕胺诱导的皮肤毒性提供基础.
主要方法:
- 网络药理学和数据挖掘被用来分析与阿帕胺相关的皮肤不良事件.
- 信息组件和报告几率比率方法评估了阿帕胺-皮肤不良事件关系.
- 分子对接探索了阿帕胺在斯蒂芬·约翰逊综合征/有毒表皮解中的潜在机制.
主要成果:
- 观察到皮肤不良事件的中位发病时间为55天,确定了21个不同的事件.
- 低体重和晚年已成为阿帕胺相关皮肤不良事件的潜在风险因素.
- 在阿帕胺和斯蒂芬·约翰逊综合征/有毒表皮解之间发现了显著的关联,这种关联可能是由阿帕胺与JAK1和JAK2结合的媒介.
结论:
- 在阿帕胺治疗期间,建议密切监测皮肤不良事件,特别是严重或快速进展的反应.
- 需要进一步的研究来阐明Janus激酶,阿帕胺和皮肤不良事件的发生之间的确切关系.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
485
相关概念视频
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Structure-Activity Relationships and Drug Design
480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
